Skip to main content
Account

Peer review reports

From: Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study

Original Submission
20 Sep 2018 Submitted Original manuscript
25 Sep 2018 Reviewed Reviewer Report - Tetsuhiko Asao
2 Nov 2018 Author responded Author comments - Ana Fernandez Montes
Resubmission - Version 2
2 Nov 2018 Submitted Manuscript version 2
8 Nov 2018 Author responded Author comments - Ana Fernandez Montes
Resubmission - Version 3
8 Nov 2018 Submitted Manuscript version 3
14 Nov 2018 Author responded Author comments - Ana Fernandez Montes
Resubmission - Version 4
14 Nov 2018 Submitted Manuscript version 4
Publishing
16 Nov 2018 Editorially accepted
29 Nov 2018 Article published 10.1186/s12885-018-5101-3

Learn about peer review

Back to article page

Navigation